- Employees in region:
- HQ location:
- San Franciso, CA
Medivation Inc. is focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation?s goal is to transform the treatment of these diseases and offer hope to critically ill patients and their families. With the approval of XTANDI® (enzalutamide) in August 2012 and the product launch immediately following, Medivation is continuing to build and develop a world-class workforce to take the company to the next strategic level. Medivation?s XTANDI® is a prescription medicine used to treat men with prostate cancer that is resistant to medical or surgical treatments that lower testosterone and that has spread to other parts of the body.
Independently Medivation has other ongoing programs in multiple different indications in early stages of research and development. Medivation is made up of a vibrant, energized group of employees that are proud to be working for an innovative, biopharmaceutical company. Medivation?s culture is evidenced through the trust and passion that its employees exhibit, creating a unique community where people are committed to making a difference in the lives of patients.
“Great manager and company. Treated with respect and compensated well for doing something I love. Excitement about the future of the organization.”
“I love the people I work with.”
“It is innovative. We are changing the natural history of prostate cancer. We have a tremendous culture. ”
“It's is challenging and full of learning opportunities.”
“Medivation values its employees and allows them to perform at their best.”
“The benefits, compensation, facilities and leadership are all amazing!”